Compounds > methamphetamine

methamphetamine and urb 597

methamphetamine has been researched along with urb 597 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chavant, F; Duranti, A; Francheteau, M; Gennequin, B; Maccarrone, M; Makriyannis, A; Nader, J; Rapino, C; Solinas, M; Thiriet, N1
Fukumori, R; Nawata, Y; Yamaguchi, T; Yamamoto, T1
Ebrahimi-Ghiri, M; Khakpai, F; Zarrindast, MR1

Other Studies

3 other study(ies) available for methamphetamine and urb 597

ArticleYear
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.
    Neuropharmacology, 2014, Volume: 87

    Topics: Animals; Arachidonic Acids; Benzamides; Benzodioxoles; Cannabinoid Receptor Modulators; Carbamates; Central Nervous System Stimulants; Dronabinol; Endocannabinoids; Enzyme Inhibitors; Glycerides; Male; Methamphetamine; Mice, Inbred C57BL; Neostriatum; Neurotoxicity Syndromes; Piperidines; Polyunsaturated Alkamides; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase

2014
Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
    The international journal of neuropsychopharmacology, 2019, 02-01, Volume: 22, Issue:2

    Topics: Amidohydrolases; Amphetamine-Related Disorders; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Addictive; Behavior, Animal; Benzamides; Benzodioxoles; Cannabinoid Receptor Antagonists; Carbamates; Central Nervous System Stimulants; Male; Maze Learning; Methamphetamine; Monoacylglycerol Lipases; Piperidines; Rats; Rats, Wistar

2019
URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels.
    Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:7

    Topics: Amidohydrolases; Animals; Anxiety; Behavior, Animal; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Central Nervous System Stimulants; Depression; Disease Models, Animal; Endocannabinoids; Male; Methamphetamine; Mice; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Substance Withdrawal Syndrome; TRPV Cation Channels

2021